The Problem of Thromboembolism in Patients with Osteoporosis

Authors

  • V.V. Povoroznyuk State Institution «Institute of Gerontology named after D.F. Chebotarev of National Academy of Medical Sciences of Ukraine»; Ukrainian Scientifi c and Practical Center of Osteoporosis Problems, Kyiv http://orcid.org/0000-0002-9770-4113
  • N.V. Grigoryeva State Institution «Institute of Gerontology named after D.F. Chebotarev of National Academy of Medical Sciences of Ukraine»; Ukrainian Scientifi c and Practical Center of Osteoporosis Problems, Kyiv

DOI:

https://doi.org/10.22141/2224-1507.1.9.2013.81964

Abstract

.

Downloads

Download data is not yet available.

References

Макацария А.Д., Бицадзе В.О.Заместительная гормональная терапия: «за и против». http://www.medlinks.ru/article.php?sid=9183.

Медицина климактерия / Под ред. В.П. Сметник. — М., 2006. — 847 с.

Поворознюк В.В., Григорьева Н.В. Менопауза и костно-мышечная система. — К.: Експрес, 2004. — 512 с.

Baglin T., Luddington R., Brown K., Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study // Lancet. — 2003. — 362. — P. 523-526.

Bolland M.J., Avenell A., Baron J.A. et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis // BMJ. — 2010. — 341. — P. 3691.

Bolland M.J., Grey A., Avenell A. et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis // BMJ. — 2011. — 342. — d2040.

Bolland M.J., Barber P.A., Doughty R.N. et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial // BMJ. — 2008. — 336. — P. 262-266.

Breart G., Cooper C., Meyer O. et al. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database // Osteoporos. Int. — 2010. — 21(7). — P. 1181-1187.

Cigolini M., Iagulli M.P., Miconi V. et al.Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients // Diabetes Care. — 2006. — 29. — P. 722-724.

Clarke S.C., Kelleher J., Lloyd-Jones H. et al. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study // BJOG. — 2002. — 109. — P. 1056-1062.

Clinical trials of hormonal replacement therapy for cardiovascular prevention in all type of patients. — http://www.trialresultscenter.org/textify_t/452-cardiovascular%20prevention-hormonal%20 replacement%20therapy.pdf.

Cushman M., Albert W., Tsai, Richard H. et al. Deep Vein Thrombosis and Pulmonary Embolism in Two Cohorts: The Longitudinal Investigation of Thromboembolism Etio­logy // American Journal of Medicine. — 2004. — 117. — P. 19-25.

Cushman M., Legault C., Barrett-Connor E. et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study // Circulation. — 1999. — 100. — P. 717-722.

EMEA Press Release 2012. [last accessed: 15.03.2012]http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2012/03/WC500124208.pdf.

ESPRIT Team. Oestrogen therapy for prevention of re-infarction in postmenopausal women: a randomized controlled trial // Lancet. — 2002. — 359. — P. 2001-2008.

Fimognari F.L., Repetto L., Moro L. et al. Age, cancer, and the risk of venous thromboembolism // Crit. Rev. Oncol. Hematol. — 2005. — 55. — P. 207-212.

General Practice Research Database. — http://www.gprd.com/home.

Gomez M., Deitcher S. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review // Archives of Internal Medicine. — 2004. — 164. — P. 1965-1976.

Grady D., Ettinger B., Moscarelli E. et al. Multiple Outcomes of Raloxifene Evaluation Investigators Safety and adverse effects associated with raloxifene: Multiple outcomes of raloxifene evaluation // Obstet. Gynecol. — 2004. — 104. — P. 837-844.

Grady D., Wenger N., Herrington D. et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study //Annals of Internal Medicine. — 2000. — 132. — P. 689-696.

Grosso A., Douglas I., Hingorani A. et al. Post-marketing assessment of the safety of strontiumranelate; a novel case-only approach to the early detection of adverse drug reactions // Br. J. Clin. Pharmacol. — 2008. — 66(5). — P. 689-694.

Heit J., Cohen A., Anderson F.J. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US // Blood. — 2005. — 106. — P. 267A.

Heit J., Kobbervig C., James A. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism during pregnancy or the puerperium: A 30-year population-based study // Annals of Internal Medicine. — 2005. — 143. — P. 697-706.

Heit J., Mohr D., Silverstein M. et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a po­pulation-based cohort study // Archives of Internal Medicine. — 2000. — 160. — P. 761-768.

Heit J., Petterson T., Farmer S. et al. Trends in Incidence of deep vein thrombosis and pulmonar embolism: a 35-year population-based study // Blood. — 2006. — 108. — P. 430a.

Heit J., Silverstein M., Mohr D. et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a po­pulation-based, cohort study // Archives of Internal Medicine. — 1999. — 159. — P. 445-453.

Heit J.A. The epidemiology of venous thromboembolism in the community // Arterioscler. Thromb. Vasc. Biol. — 2008. — 28. — P. 370-372.

Heit J.A. Venous thromboembolism epidemiology: implications for prevention and management // Semin. Thromb. Hemost. — 2002. — 28 (Suppl. 2). — P. 3-13.

Heit J.A., Silverstein M.D., Mohr D.N. et al. The epidemio­logy of venous thromboembolism in the community // Thromb. Haemost. — 2001. — 86. — P. 452-463.

Hoibraaten E., Qvigstad E., Arnesen H. et al. Increased risk of recurrent venous thromboembolism during hormone replacement therapy. Results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) // Thromb. Haemost. — 2000. — 84. — P. 961-967.

Holmberg L., Anderson H. for the HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped // Lancet. — 2004. — 363. — P. 453-455.

Hooper W., Holman R., Heit J., Cobb N. Venous thromboembolism hospitalizations among American Indians and Alaska Natives // Thrombosis Research. — 2002. — 108. — P. 273-278.

Hulley S., Grady D., Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group // JAMA. — 1998. — 280. — P. 605-613.

Janata K., Holzer M., Domanovits H. et al. Mortality of patients with pulmonary embolism // Wiener Medizinische Wochenschrift. — 2002. — 114. — P. 766-772.

Kearon C., Gent M., Hirsch J. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism // New England Journal of Medicine. — 1999. — 340. — P. 901-907.

Kesteven P.J.L. Traveller’s Thrombosis // Thorax. — 2000. — 55(Suppl. 1). — S. 32-36.

Koh K.K., Horne M.K. III, Cannon R.O. III. Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women // Thromb. Haemost. — 1999. — 82. — P. 26-33.

Kwong L.M. Hip fracture and venous thromboembolism in the elderly // J. Surg. Orthop. Adv. — 2004. — 13. — P. 139-148.

Kyrle P.A., Eichinger S. Venous thromboembolism in men and women // J. Men’s Health & Gender. — 2005. — 2. — P. 302-308.

LaCroix A.Z., Kotchen J., Anderson G. et al.Calcium plus vitamin D supplementation and mortality in postmenopau­sal women: the Women’s Health Initiative calcium-vitamin D randomized controlled trial // J. Gerontol. A Biol. Sci Med. Sci. — 2009. — 64(5). — P. 559-567.

Lee J.H., O’Keefe J.H., Bell D. et al. Vitamin D Deficiency. An Important, Common, and Easily Treatable Cardiovascular Risk Factor? // J. Am. Coll. Cardiol. — 2008. — 52(24). — P. 1949-1956.

Lewis J.R., Calver J., Zhu K. et al. Calcium supplementation and the risks of atherosclerotic vascular disease in older wo­men: results of a 5-year RCT and a 4.5-year follow-up // J. Bone Miner. Res. — 2011. — 26. — P. 35-41.

Machlus K.R., Aleman M.M., Wolberg A.S. Update on Venous Thromboembolism: Risk Factors, Mechanisms, and Treatments // Arterioscler. Thromb. Vasc. Biol. — 2011. — 31(3). — P. 476-478.

Manson J.E., Hsia J., Johnson K.C. et al. Estrogen plus progestin and the risk of coronary heart disease // N. Engl. J. Med. — 2003. — 349. — P. 523-534.

Martins D., Wolf M., Pan D. et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey // Arch. Intern. Med. — 2007. — 167. — P. 1159-1165.

McRae S., Tran H., Schulman S. et al. Effect of patient’s sex on risk of recurrent venous thromboembolism: a meta-analysis // Lancet. — 2006. — 368. — P. 371-378.

Melamed M.L., Muntner P., Michos E.D. et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease. Resultsfrom NHANES 2001 to 2004 // Arterioscler. Thromb. Vasc. Biol. — 2008. — P. 1179-1185.

Michaëlsson K., Melhus H., Lemming E.W. et al. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study // BMJ. — 2013. — 346doi: http://dx.doi.org/10.1136/bmj.f228.

Mosca L., Grady D., Barrett-Connor E. et al. Effect of Ra­loxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coro­nary Heart Disease // Stroke. — 2009. — 40(1). — P. 147-155.

Palareti G., Cosmi B., Legnani C. et al. D-Dimer Testing to Determine the Duration of Anticoagulation Therapy // N. Engl. J. Med. — 2006. — 355. — P. 1780-1789.

Poole K.E., Loveridge N., Barker P.J. et al. Reduced vitamin D in acute stroke // Stroke. — 2006. — 37. — P. 243-245.

Popuri R.K., Vedantham S. The role of thrombolysis in the clinical management of DVT // Arterioscler. Thromb. Vasc. Biol. — 2011.

Prandoni P., Lensing A.W., Prins M.H. et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism // Ann. Intern. Med. — 2002. — 137(12). — Р. 955-960.

Reginster J.Y. et al. Osteoporos Int. — 2011. — 22 (Suppl. 1). — S. 110-111, OC32.

Riggs B., Hartmann L. Selective Estrogen-Receptor Modulators // N. Engl. J. Med. — 2003. — 348. — P. 618-629.

Rosendaal F.R. Risk factors for venous thrombotic di­sease // Thromb. Haemost. — 1999. — 82. — P. 610-619.

Rosendaal F.R., HylckamaVlieg A., Doggen C.J. Venous thrombosis in the elderly // J. Thromb. Haemost. — 2007. — 5(Suppl. 1). — P. 310-317.

Rosendaal F.R., Van HylckamaVlieg A., Tanis B.C., Helmerhorst F.M. Estrogens, progestogens and thrombosis // J. Thromb. Haemost. — 2003. — 1. — Р. 1371-1380.

Rosendaal F.R., Vessey M., Rumley A. et al. Hormo­nal replacement therapy, prothrombotic mutations and the risk of venous thrombosis // Br. J. Haematol. — 2002. — 116. — P. 851-854.

Rossouw J.E., Anderson G.L., Prentice R.L. et al. Wri­ting Group for the Women’s Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial // JAMA. — 2002. — 288. — P. 321-333.

Schulman S., Svenungsson E., Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group //American Journal of Medicine. — 1998. — 104. — P. 332-338.

Schulman S., Lindmarker P., Holmstrom M. et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months // Journal of Thrombosis and Haemostasis. — 2006. — 4. — P. 732-742.

Scragg R., Jackson R., Holdaway I.M. et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study // Int. J. Epidemiol. — 1990. — 19. — P. 559-563.

Shah S.M., Carey I.M., Harris T. et al. Calcium supplementation, cardiovascular disease and mortality in older women // Pharmacoepidemiol. Drug Saf. — 2010. — 19(1). — P. 59-64.

Silverstein M., Heit J., Mohr D. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based, cohort study // Archives of Internal Medicine. — 1998. — 158. — P. 585-593.

Silverstein R.L., Bauer K.A., Cushman M. et al. Venous thrombosis in the elderly: more questions than answers // Blood. — 2007. — 110. — P. 3097-3101.

Spencer F.A., Emery C., Lessard D. et al. The Worcester Venous Thromboembolism Study A Population-Based Study of the Clinical Epidemiology of Venous Thromboembolism // J. Gen. Intern. Med. — 2006. — 21(7). — P. 722-727.

Spyropoulos A.C., Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations // J. Manag. Care Pharm. — 2007. — 13. — P. 475-486.

Stefanick M.L. Risk-benefit profiles of raloxifene for wo­men // N. Engl. J. Med. — 2006. — 355. — P. 190-192.

Symington I.S., Stack B.H.R. Pulmonary thromboembolism after travel // Br. J. Chest. — 1977. — 17. — P. 138-140.

Teede H.J., McGrath B.P., Smolich J.J. et al. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis // Arterioscler. Thromb. Vasc. Biol. — 2000. — 20. — P. 1404-1409.

Van den Belt A., Sanson B.-J., Simioni P. et al. Recurrence of venous thromboembolism in patients with fami­lial thrombophilia // Archives of Internal Medicine. — 1997. — 157. — P. 227-232.

Van Dongen C., Vink R., Hutten B. et al. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis // Archives of Internal Medicine. — 2003. — 163. — P. 1285-1293.

Veerus P., Hovi S., Fischer K. et al. Results from the Estonian postmenopausal hormone therapy trial // Maturitas. — 2006. — 55. — P. 162-173.

Vickers M.R., MacLennan A.H., Lawton B. et al. Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women // BMJ. — 2007. — 4. — 335(7613). — P. 239.

Viscoli C.M., Brass L.M., Kernan W.N. et al. A clinical trial of estrogen-replacement therapy after ischemic stroke // N. Engl. J. Med. — 2001. — 345. — P. 1243-1249.

Waters D.D., Alderman E.L., Hsia J. et al. Effects of hormone replacement therapy and antioxidant vitamin in postmenopausal supplements on coronary atherosclerosis in postmenopau­sal women: a randomized controlled trial // JAMA. — 2002. — 288. — P. 2432-2440.

White R., Zhou H., Romano P. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California // Annuals of Internal Medicine. — 1998. — 128. — P. 737-740.

White R.H. The epidemiology of venous thromboembolism // Circulation. — 2003. — 107. — P. 14-18.

Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The women’s health initiative randomised controlled trial // JAMA. — 2004. — 291. — P. 1701-1712.

Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women’s health initiative randomized controlled trial // JAMA. — 2002. — 288. — P. 321-333.

Published

2022-01-20

How to Cite

Povoroznyuk, V., & Grigoryeva, N. (2022). The Problem of Thromboembolism in Patients with Osteoporosis. PAIN, JOINTS, SPINE, (1.09), 5–17. https://doi.org/10.22141/2224-1507.1.9.2013.81964

Issue

Section

Problem of This Issue

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>